This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Butler, J. Articles by Griffin, M. R. Search for Related Content PubMed PubMed Citation Articles by Butler, J. Articles by Griffin, M. R.

Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge

Javed Butler, MD, MPH, FACC^*||,*, Patrick G. Arbogast, PhD, James Daugherty, MS, Manoj K. Jain, MD, MPH^||, Wayne A. Ray, PhD and Marie R. Griffin, MD, MPH

^* Cardiology Division, Vanderbilt University, Nashville, Tennessee, USA
Department of Preventive Medicine, Vanderbilt University, Nashville, Tennessee, USA
Center for Education and Research in Therapeutics, Vanderbilt University, Nashville, Tennessee, USA
Geriatrics Research, Education, and Clinical Center, Nashville VAMC, Nashville, Tennessee, USA
^|| Centers for Healthcare Quality Inc., Memphis, Tennessee, USA

View larger version (16K): [in a new window]   Figure 1 Angiotensin-converting enzyme inhibitor (ACEI) use after discharge from hospitalization for decompensated heart failure patients with depressed ejection fraction. Use of ACEI is shown among patients who were and were not given a prescription for them at discharge. The adherence is shown from discharge to one year postdischarge and includes patients who were alive at any given time period.

View larger version (16K): [in a new window]   Figure 2 Angiotensin-converting enzyme inhibitor (ACEI) use after discharge from hospitalization for patients with decompensated heart failure. Data similar to Figure 1 are shown for the total cohort.